NEW YORK (AP) — Drug developer Pfizer Inc. said Tuesday it signed a deal with Bausch & Lomb- to co-promote prescription eye-care drugs in the U.S. Terms of the five-year deal were not disclosed. The partnership includes Pfizer’s eye-care solution Xalatan and Bausch & Lomb’s Alrex, among other products. Meanwhile, Pfizer said it will continue to maintain three developing eye-care products separate from the partnership. The eye-care announcement follows New York-based Pfizer’s move to begin selling dozens more generic drugs in the U.S. and Europe through new deals with Indian generic company Aurobindo Pharma Ltd.